Literature DB >> 19319505

Inherited susceptibility to non-alcoholic fatty liver disease.

R J F Loos1, D B Savage.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19319505     DOI： 10.1007/s00125-009-1339-2

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  16 in total

1.  Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members.

Authors:  Andrew C Lake; Ying Sun; Jian-Liang Li; Jae Eun Kim; Jeremy W Johnson; Dongmei Li; Tracy Revett; Heather H Shih; Wei Liu; Janet E Paulsen; Ruth E Gimeno
Journal:  J Lipid Res       Date:  2005-09-08       Impact factor: 5.922

2.  Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.

Authors:  Kitt Falk Petersen; Sylvie Dufour; Jing Feng; Douglas Befroy; James Dziura; Chiara Dalla Man; Claudio Cobelli; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

3.  Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage.

Authors:  S Baulande; F Lasnier; M Lucas; J Pairault
Journal:  J Biol Chem       Date:  2001-06-28       Impact factor: 5.157

4.  Variation in the adiponutrin gene influences its expression and associates with obesity.

Authors:  Lovisa E Johansson; Johan Hoffstedt; Hemang Parikh; Emma Carlsson; Martin Wabitsch; Anne-Greth Bondeson; Jan Hedenbro; Hans Tornqvist; Leif Groop; Martin Ridderstråle
Journal:  Diabetes       Date:  2006-03       Impact factor: 9.461

5.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Authors:  Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

6.  Splanchnic lipolysis in human obesity.

Authors:  Soren Nielsen; ZengKui Guo; C Michael Johnson; Donald D Hensrud; Michael D Jensen
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

7.  A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans.

Authors:  A Kotronen; L E Johansson; L M Johansson; C Roos; J Westerbacka; A Hamsten; R Bergholm; P Arkkila; J Arola; T Kiviluoto; R M Fisher; E Ehrenborg; M Orho-Melander; M Ridderstråle; L Groop; H Yki-Järvinen
Journal:  Diabetologia       Date:  2009-02-18       Impact factor: 10.122

8.  Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities.

Authors:  Christopher M Jenkins; David J Mancuso; Wei Yan; Harold F Sims; Beverly Gibson; Richard W Gross
Journal:  J Biol Chem       Date:  2004-09-10       Impact factor: 5.157

Review 9.  Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice.

Authors:  Catherine Postic; Jean Girard
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

Review 10.  Fatty liver: a novel component of the metabolic syndrome.

Authors:  Anna Kotronen; Hannele Yki-Järvinen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-08-09       Impact factor: 8.311
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.